Short Interest in Select Medical Holdings Co. (NYSE:SEM) Grows By 32.9%

Select Medical Holdings Co. (NYSE:SEM) saw a significant growth in short interest in August. As of August 31st, there was short interest totalling 3,190,000 shares, a growth of 32.9% from the August 15th total of 2,400,000 shares. Approximately 2.9% of the company’s shares are short sold. Based on an average trading volume of 749,000 shares, the short-interest ratio is presently 4.3 days.

In other Select Medical news, CEO David S. Chernow sold 139,550 shares of the stock in a transaction on Monday, August 9th. The shares were sold at an average price of $36.14, for a total transaction of $5,043,337.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Marilyn B. Tavenner sold 10,000 shares of the stock in a transaction on Monday, August 9th. The shares were sold at an average price of $36.23, for a total transaction of $362,300.00. Following the transaction, the director now owns 24,000 shares in the company, valued at $869,520. The disclosure for this sale can be found here. 18.80% of the stock is owned by corporate insiders.

A number of hedge funds have recently bought and sold shares of SEM. Eaton Vance Management acquired a new stake in shares of Select Medical during the 1st quarter worth $39,000. Mark Sheptoff Financial Planning LLC acquired a new stake in shares of Select Medical during the first quarter valued at about $68,000. Emerald Advisers LLC acquired a new stake in shares of Select Medical during the second quarter valued at about $120,000. FORA Capital LLC bought a new position in shares of Select Medical during the first quarter worth about $161,000. Finally, Captrust Financial Advisors raised its position in shares of Select Medical by 2,354.3% during the first quarter. Captrust Financial Advisors now owns 5,154 shares of the health services provider’s stock worth $176,000 after acquiring an additional 4,944 shares during the last quarter. Hedge funds and other institutional investors own 77.13% of the company’s stock.

NYSE:SEM traded up $0.10 during trading hours on Tuesday, reaching $34.92. 32,585 shares of the stock were exchanged, compared to its average volume of 717,505. Select Medical has a twelve month low of $18.24 and a twelve month high of $43.60. The company has a debt-to-equity ratio of 2.34, a current ratio of 1.33 and a quick ratio of 1.33. The firm has a 50 day moving average of $36.33 and a 200 day moving average of $37.35. The stock has a market cap of $4.70 billion, a PE ratio of 10.95, a PEG ratio of 0.75 and a beta of 1.36.

Select Medical (NYSE:SEM) last released its quarterly earnings data on Thursday, August 5th. The health services provider reported $1.22 EPS for the quarter, beating the consensus estimate of $0.60 by $0.62. The company had revenue of $1.56 billion during the quarter, compared to the consensus estimate of $1.51 billion. Select Medical had a return on equity of 32.52% and a net margin of 7.17%. Equities research analysts anticipate that Select Medical will post 3.05 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Monday, August 30th. Investors of record on Wednesday, August 18th were paid a $0.125 dividend. This represents a $0.50 dividend on an annualized basis and a yield of 1.43%. The ex-dividend date was Tuesday, August 17th. Select Medical’s dividend payout ratio (DPR) is presently 26.46%.

A number of research firms have recently commented on SEM. Benchmark lifted their price target on shares of Select Medical from $44.00 to $50.00 and gave the company a “buy” rating in a research report on Wednesday, June 23rd. Credit Suisse Group boosted their target price on shares of Select Medical from $37.00 to $39.00 and gave the company a “neutral” rating in a research note on Tuesday, August 10th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, Select Medical currently has a consensus rating of “Buy” and an average target price of $42.20.

Select Medical Company Profile

Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation and Concentra. The Critical Illness Recovery Hospital segment serves patients with debilitating injuries and rehabilitation needs that cannot be adequately cared in a medically intensive environment, such as a skilled nursing facility.

Recommended Story: Stock Selection – What is cash flow?

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.